As there is (almost) no insulin production in patients with T1DM, it has been hypothesized that low insulin concentrations in the portal vein cause decreased IGF1 concentrations/bioactivity through both GH receptor- and IGFBP1-mediated mechanisms (5, 8). This evidence concerns the gene IGFBP1 and type 1 diabetes mellitus.